PSG completed the investment in Riveran-backed Corilus.

PSG, a growth equity firm, completed the investment in Riveran-backed Corilus, a provider of medical software solutions. Financial terms were not disclosed. “Under the leadership of Dirk alongside Rivean, Corilus has established its position as a leading medical software solutions provider with an impressive offering and client base. We are excited to combine our expertise growing European software champions with Corilus’ talented team to support the expansion of product offerings and functionality, including through the potential of GenAI solutions to assist practitioners, and enter new markets. We see great potential for continued growth through innovation as we seek to accelerate Corilus’ mission to develop a smart and efficient healthcare system,” Dany Rammal, PSG Managing Director.